NASDAQ:OPRX OptimizeRx Q3 2026 Earnings Date & Estimates $9.29 -0.18 (-1.90%) As of 03:11 PM Eastern This is a fair market value price provided by Massive. Learn more. OptimizeRx is estimated to report Q3 2026 earnings on Wednesday, November 11, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 11, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from OptimizeRx in Q3 2026OptimizeRx is expected to post earnings of $0.18 per share on revenue of $21.19 million. In the same quarter a year earlier OptimizeRx reported $0.20 per share on revenue of $26.07 million. OptimizeRx last reported on August 12, 2026, posting $0.16 per share and beating the $0.1111 consensus estimate. OptimizeRx has beaten the consensus EPS estimate in 7 of its last 8 quarters.Consensus EstimatesConsensus EPS$0.18Expected Revenue$21.19 millionPrior-Year EPS$0.20Prior-Year Revenue$26.07 millionExpected EPS Growth-10.0%Expected Revenue Growth-18.7%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS$0.16 (Beat by +$0.0489)Last Quarter Revenue$20.50 millionEPS Beat Rate7 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report OptimizeRx Q3 2026 Earnings FAQ When does OptimizeRx report Q3 2026 earnings? OptimizeRx (NASDAQ:OPRX) is estimated to report Q3 2026 earnings on Wednesday, November 11, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is OptimizeRx's Q3 2026 earnings call? OptimizeRx's Q3 2026 earnings conference call is scheduled for Wednesday, November 11, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for OptimizeRx? Analysts expect OptimizeRx to post earnings of $0.18 per share for Q3 2026. How much revenue is OptimizeRx expected to report? The consensus revenue estimate for OptimizeRx is $21.19 million for Q3 2026. OptimizeRx Earnings HeadlinesEarnings To Watch: OptimizeRx Corp (OPRX) Q3 2026 -- GF Value Sees 30.10% Upside2 hours ago | finance.yahoo.comOptimizeRx (OPRX) Set to Release Earnings on WednesdayNovember 10 at 1:10 AM | americanbankingnews.comMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a household name. Now he says a similar shift is unfolding in AI infrastructure. Hundreds of billions are pouring into AI data centers, but he warns the builders could get crushed by their own costs while one overlooked sector absorbs the spending.November 10 at 1:00 AM | Porter & Company (Ad)Why OptimizeRx Bears Were Right Before A 52% DropNovember 4, 2026 | finance.yahoo.comOptimizeRx Sets Third Quarter 2026 Conference Call for November 11, 2026 at 4:30 p.m. ETOctober 28, 2026 | globenewswire.comOptimizeRx and PulsePoint Partner to Connect HCP Media Across the FunnelOctober 27, 2026 | globenewswire.comSee More OptimizeRx Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like OptimizeRx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on OptimizeRx and other key companies, straight to your email. Email Address About OptimizeRxOptimizeRx (NASDAQ:OPRX) Corporation (NASDAQ: OPRX) is a digital health and life sciences technology company that helps pharmaceutical and biotechnology companies connect with healthcare professionals and patients. Its platform supports prescription-related communications, treatment access, affordability, adherence and patient engagement throughout the medication journey. The company provides solutions that can be integrated into electronic health records and other healthcare workflows. Its offerings include point-of-care messaging for healthcare professionals, patient support and savings programs, medication access tools, and data and analytics services designed to help life sciences companies communicate with relevant audiences and understand engagement. OptimizeRx was founded in 2006 and has primarily served the U.S. healthcare market, working with pharmaceutical manufacturers, healthcare providers and patients. The company is led by co-founder and Chief Executive Officer William Febbo. Its business focuses on using digital communications and healthcare data to improve connections among life sciences companies, clinicians and patients.View OptimizeRx ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles DraftKings Just Lost 20%—And Its Biggest Gamble Is Still AheadBarrick's Earnings Beat Could Be Overshadowed by an Even Bigger OpportunityAxon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings?Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?Wall Street May Be Making a Big Mistake With monday.com StockCloudflare's 20% Sell-Off May Have Created an Opening for InvestorsMarketBeat Week in Review – 11/2 - 11/6 Upcoming Earnings Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026)Cisco Systems (11/12/2026)Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
